TIM
AVXL icon

Thompson Investment Management’s Anavex Life Sciences AVXL Stock Holding History

Thompson Investment Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,000
Closed -$11.4K – 501
2024
Q3 		$11.4K Hold
2,000
– – ﹤0.01% 379
2024
Q2 		$8.44K Hold
2,000
– – ﹤0.01% 393
2024
Q1 		$10.2K Hold
2,000
– – ﹤0.01% 400
2023
Q4 		$18.6K Hold
2,000
– – ﹤0.01% 291
2023
Q3 		$13.1K Buy
+2,000
New +$15.9K ﹤0.01% 305

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Thompson Investment Management's AVXL Position: Q4 2024 in Review

Thompson Investment Management sold out of Anavex Life Sciences (AVXL) in Q4 2024, closing a stake of 2,000 shares — an estimated $11.4K sold.

Thompson Investment Management first reported a position in AVXL in Q3 2023 and held it in 5 quarters. The position peaked at $18.6K in Q4 2023. 168 funds tracked by Wall St. Rank hold AVXL as of Q4 2024.

  • Thompson Investment Management reported no remaining Anavex Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Thompson Investment Management sold 2,000 Anavex Life Sciences shares in Q4 2024, an estimated $11.4K.
  • Thompson Investment Management first reported a position in Anavex Life Sciences in Q3 2023 and held it in 5 quarters.
  • Thompson Investment Management's Anavex Life Sciences position peaked at $18.6K in Q4 2023.
  • 168 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2024.

Based on Thompson Investment Management's 13F filing for Q4 2024, filed 28 Jan 2025.